Literature DB >> 25225288

Development of isoform-specific sensors of polypeptide GalNAc-transferase activity.

Lina Song1, 丽娜 宋1, Collin Bachert1, Katrine T Schjoldager2, Henrik Clausen2, Adam D Linstedt3.   

Abstract

Humans express up to 20 isoforms of GalNAc-transferase (herein T1-T20) that localize to the Golgi apparatus and initiate O-glycosylation. Regulation of this enzyme family affects a vast array of proteins transiting the secretory pathway and diseases arise upon misregulation of specific isoforms. Surprisingly, molecular probes to monitor GalNAc-transferase activity are lacking and there exist no effective global or isoform-specific inhibitors. Here we describe the development of T2- and T3-isoform specific fluorescence sensors that traffic in the secretory pathway. Each sensor yielded little signal when glycosylated but was strongly activated in the absence of its glycosylation. Specificity of each sensor was assessed in HEK cells with either the T2 or T3 enzymes deleted. Although the sensors are based on specific substrates of the T2 and T3 enzymes, elements in or near the enzyme recognition sequence influenced their activity and required modification, which we carried out based on previous in vitro work. Significantly, the modified T2 and T3 sensors were activated only in cells lacking their corresponding isozymes. Thus, we have developed T2- and T3-specific sensors that will be valuable in both the study of GalNAc-transferase regulation and in high-throughput screening for potential therapeutic regulators of specific GalNAc-transferases.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Biosensor; Fluorescence; Glycosylation; Glycosyltransferase; Golgi; Protein Processing

Mesh:

Substances:

Year:  2014        PMID: 25225288      PMCID: PMC4215235          DOI: 10.1074/jbc.M114.599563

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.

Authors:  Katrine Ter-Borch Gram Schjoldager; Malene B Vester-Christensen; Christoffer K Goth; Thomas Nordahl Petersen; Søren Brunak; Eric P Bennett; Steven B Levery; Henrik Clausen
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  Vertebrate protein glycosylation: diversity, synthesis and function.

Authors:  Kelley W Moremen; Michael Tiemeyer; Alison V Nairn
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

Review 3.  Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation.

Authors:  J C Paulson; K J Colley
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

4.  Expression of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer.

Authors:  T Kohsaki; I Nishimori; H Nakayama; E Miyazaki; H Enzan; M Nomoto; M A Hollingsworth; S Onishi
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

5.  A sensitive green fluorescent protein biomarker of N-glycosylation site occupancy.

Authors:  Marie-Estelle Losfeld; Francesca Soncin; Bobby G Ng; Ilyas Singec; Hudson H Freeze
Journal:  FASEB J       Date:  2012-06-12       Impact factor: 5.191

6.  Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy.

Authors:  Joseph N Contessa; Mahaveer S Bhojani; Hudson H Freeze; Brian D Ross; Alnawaz Rehemtulla; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2010-04-22       Impact factor: 12.531

7.  The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.

Authors:  Thomas A Gerken; Leslie Revoredo; Joseph J C Thome; Lawrence A Tabak; Malene Bech Vester-Christensen; Henrik Clausen; Gagandeep K Gahlay; Donald L Jarvis; Roy W Johnson; Heather A Moniz; Kelley Moremen
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

8.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Authors:  Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

9.  Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.

Authors:  S Kitada; S Yamada; A Kuma; S Ouchi; T Tasaki; A Nabeshima; H Noguchi; K-Y Wang; S Shimajiri; R Nakano; H Izumi; K Kohno; T Matsumoto; Y Sasaguri
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 7.640

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  8 in total

1.  Activity Detection of GalNAc Transferases by Protein-Based Fluorescence Sensors In Vivo.

Authors:  Lina Song; Collin Bachert; Adam D Linstedt
Journal:  Methods Mol Biol       Date:  2016

Review 2.  Advances in Activity-Based Sensing Probes for Isoform-Selective Imaging of Enzymatic Activity.

Authors:  Sarah H Gardner; Christopher J Reinhardt; Jefferson Chan
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-11       Impact factor: 15.336

3.  Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines.

Authors:  John Hintze; Zilu Ye; Yoshiki Narimatsu; Thomas Daugbjerg Madsen; Hiren J Joshi; Christoffer K Goth; Adam Linstedt; Collin Bachert; Ulla Mandel; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

4.  Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.

Authors:  Shoko Nakamura; Masayuki Horie; Tomo Daidoji; Tomoyuki Honda; Mayo Yasugi; Atsushi Kuno; Toshihisa Komori; Daisuke Okuzaki; Hisashi Narimatsu; Takaaki Nakaya; Keizo Tomonaga
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

5.  Site-specific glycosylation of Ebola virus glycoprotein by human polypeptide GalNAc-transferase 1 induces cell adhesion defects.

Authors:  Emily J Simon; Adam D Linstedt
Journal:  J Biol Chem       Date:  2018-11-02       Impact factor: 5.157

6.  Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.

Authors:  Lina Song; Adam D Linstedt
Journal:  Elife       Date:  2017-03-31       Impact factor: 8.140

7.  GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice.

Authors:  Xuedan Li; Yiliang Zhang; Minzhu Zhang; Yan Wang
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

Review 8.  Genetic glycoengineering in mammalian cells.

Authors:  Yoshiki Narimatsu; Christian Büll; Yen-Hsi Chen; Hans H Wandall; Zhang Yang; Henrik Clausen
Journal:  J Biol Chem       Date:  2021-02-20       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.